1. A pharmaceutical composition comprising zanamivir, and one or more pharmaceutically acceptable excipients, wherein the total daily dose of zanamivir is less than 10 mg.2. A pharmaceutical composition according to claim 1 for administration at least once a den.3. A pharmaceutical composition according to claim 1, wherein the composition delivers from 3 mg to 8 mg per administered zanamivir dozu.4. The pharmaceutical composition of claim 1 designed for administration by a dry powder inhaler (DPI), metered dose inhaler (MDI), nebulizer, nasal spray, nasal drops or powders for vduvaniya.5. A pharmaceutical composition according to claim 4, designed for use as a dry powder formulation for ingalyatsiy.6. A pharmaceutical composition according to claim 5, further comprising at least one particulate pharmaceutically acceptable carrier suitable for use in dry powder forms for ready ingalyatsiy.7. Combination composition according to claim 6, wherein said carrier comprises a saccharide and / or sugar spirt.8. A pharmaceutical composition according to any one of claims 5, 6 or 7, wherein the pharmaceutical composition is contained in a capsule or is contained in blisters or enclosed inside the tank in a single dose or multiple dose inhalation device for dry poroshka.9. A pharmaceutical composition according to any one of claims 5, 6 or 7, wherein the pharmaceutical composition is administered by Revolizer ™ .10. A pharmaceutical composition according to any one of claims 1-7, further comprising one or more active substance (active agent) selected from amantadine, rimantadine, acyclovir, AZT, vidarabine, ribavirin, dapsone, chloramphenicol, not1. Фармацевтическая композиция, содержащая занамивир и один или более фармацевтически приемлемых эксципиентов, в которой общая суточная доза занамивира составляет менее чем 10 мг.2. Фармацевтическая композиция по п.1 для введения по меньшей мере один раз в день.3. Фармацевтическая композиция по п.1, при этом композиция доставляет от 3
